Purified preparations contained more than 90% of CD85j+ cells.
The cell preparations contained more than 95% tumor cells as determined by size and TCR Vβ measured by flow cytometry (data not shown).
The proportion of macrophages in the peritoneal exudate was determined by cell staining with May-Gruenwald-Giemsa. Cell preparations contained more than 95% macrophages.
The final cell preparations contained more than 75 80% monocytes, based on their morphology and nonspecific esterase staining; their viability was greater than 98%, as assessed by trypan blue exclusion.
As a control, a transgenically produced recombinant BChE preparation containing more than 70% tetramer was also injected i.v. into 4 juvenile pigs at a dose of 10 mg/kg.
This enzyme preparation contains more than 130 proteins and is particularly rich in enzymes active on hemicelluloses and pectins, many of which could potentially contribute to Glc yield (JS Scott-Craig and JD Walton, unpublished results).
The value of x could be wrong either because the composition of the initial mix used in the synthesis procedure was simply assumed to apply to the solid and was not checked, or because of incorrect interpretation of the bulk analysis if the preparation contained more than one phase.
More recent studies have reported that the long-term use of preparations containing progestins is more detrimental than the use of oestrogen alone [ 60, 61].
Biocidal products are preparations containing one or more active substances, with the intention of "destroying, deterring, rendering harmless, preventing the action of, or otherwise exerting a controlling effect on, any organism by any means other than mere physical or mechanical" (Biocidal Products Regulation, (EU) No 528/2012, BPR)[1].
DNA vaccines are purified plasmid preparations containing one or more DNA sequences of the pathogen of interest that are expressed in the recipient on delivery.
